Human evidence for this concept is that ARB use, as compared to the use of other classes of antihypertensive medications such as ACE inhibitors and Beta-blockers, is associated with lower neuritic plaque count and a reduction in neurofibrillary tangles in AD patient brain tissue (Hoffman et al., 2009; Hajjar et al., 2012). Here, ACE is linked to Alzheimer disease.